Hernandez J, Martin G, Gutierrez N, Cervera J, Ferro M, Calasanz M, Martinez-Climent J, Luno E, Tormo M, Rayon C, Diaz-Mediavilla J, Gonzalez M, Miguel JG-S, Perez-Equiza K, Rivas C, Esteve J, Mdel CA, Odriozola J, Ribera J, Sanz M, PETHA Cooperative Group, Spain. Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA. Haematologica 2001; 86(8):807-813.